Andra AP-fonden’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $3.44M | Sell |
|
|||||
|
2025
Q1 | $9.85M | Sell |
|
|||||
|
2024
Q4 | $13.7M | Sell |
|
|||||
|
2024
Q3 | $20.5M | Buy |
|
|||||
|
2024
Q2 | $22.2M | Buy |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $9.59M | Buy |
|
|||||
|
2023
Q3 | $6.14M | Sell |
|
|||||
|
2023
Q2 | $6.4M | Sell |
|
|||||
|
2023
Q1 | $10.3M | Buy |
|
|||||
|
2022
Q4 | $11.1M | Buy |
|
|||||
|
2022
Q3 | $6.24M | Buy |
|
|||||
|
2022
Q2 | $4.57M | Buy |
|
|||||
|
2021
Q4 | $5.85M | Buy |
|
|||||
|
2021
Q3 | $4.94M | Sell |
|
|||||
|
2021
Q2 | $5.43M | Buy |
|
|||||
|
2021
Q1 | $1.08M | Sell |
|
|||||
|
2020
Q4 | $1.54M | Buy |
|
|||||
|
2020
Q3 | $731K | Sell |
|
|||||
|
2020
Q2 | $3.78M | Buy |
|
|||||
|
2020
Q1 | $2.31M | Buy |
|
|||||
|
2019
Q4 | $2.47M | Buy |
|